Johnson & Johnson (JNJ)

Johnson & Johnson (NYSE:JNJ ) Goldman Sachs 46th Annual Global Healthcare Conference Call June 11, 2025 3:20 PM ET Company Participants Tom Cavanaugh - Company Group Chairman for North America Innovat...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

JNJ edges ahead of MRK with stronger 2025 growth prospects, a broader pipeline and better sales momentum despite key headwinds.

Volatility is a part of life for long-term investors. The reasons the market goes up or down change, but the constant is that high-quality stocks, businesses that increasingly make more money over tim...

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) announced today that Daniel Pinto, President, JPMorganChase, has been elected to its Board of Directors. “We are thrilled to have Da...

We're at the end of earnings season. That means it's time for analysts to weigh in on the outlook for specific stocks.

Key Points Put your money to work. Make it make you money. It can make you a good deal of consistent money if you invest wisely in higher-yielding Dividend King stocks. Are you ahead, or behind on ret...

Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

In the current market climate, investors are increasingly shifting to defensive strategies. As investors navigate the turbulent waters of tariff-driven volatility in 2025, dividend stocks have emerged...

Key Points These high-yield dividend stocks haven’t disappointed me in the last decade. Each of these stocks have the potential of an upside as the economy improves. Are you ahead, or behind on retire...